End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
Prostate Cancer and Prostatic Diseases advance online publication, January 17 2017.
doi:10.1038/pcan.2016.67
Authors: A K Narang, J Trieu, N Radwan, A Ram, S P Robertson, P He, C Gergis, E Griffith, H Singh, T A DeWeese, S Honig, A Annadanam, S Greco, C DeVille, T McNutt, T L DeWeese, D Y Song & P T Tran
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: A K Narang J Trieu N Radwan A Ram S P Robertson P He C Gergis E Griffith H Singh T A DeWeese S Honig A Annadanam S Greco C DeVille T McNutt T L DeWeese D Y Song P T Tran Source Type: research